Live Status Check

NCT06228326 Recruiting Status

Real-time enrollment status for this lung cancer clinical trial

Current Status

Recruiting

Auto-verified from ClinicalTrials.gov

Checked: March 2, 2026 at 1:39 PM UTC

NCT06228326 Status Summary

NCT NumberNCT06228326
Recruiting StatusRecruiting
ConditionLung Cancer
PhaseClinical Trial
Target Enrollment200 participants
Active Locations11 sites in the US
SponsorKrystal Biotech, Inc.
Last Updated on CT.govOctober 24, 2025 (Oct 24, 2025)

About NCT06228326 Enrollment Status

As of March 2, 2026: Clinical trial NCT06228326 is currently recruiting participants. This clinical trial study for lung cancer is actively seeking new participants at 11 locations across the United States. The study is sponsored by Krystal Biotech, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.

Frequently Asked Questions About NCT06228326

Is NCT06228326 still recruiting?

Yes, NCT06228326 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.

Where is NCT06228326 recruiting?

This trial is recruiting at 11 locations in the United States. View all available locations on the full study page.

How do I enroll in NCT06228326?

Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.

When was NCT06228326 status last updated?

The official ClinicalTrials.gov record for NCT06228326 was last updated Oct 24, 2025 (October 24, 2025). HelloStudys verifies this status automatically.

Ready to Apply?

Check your eligibility for this clinical trial